Jennison Associates
IONS icon

Jennison Associates’s Ionis Pharmaceuticals IONS Stock Holding History

Jennison Associates’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-285,000
Closed -$17.6M – 731
2014
Q4 		$17.6M Hold
285,000
– – 0.02% 447
2014
Q3 		$11.1M Hold
285,000
– – 0.01% 475
2014
Q2 		$9.82M Hold
285,000
– – 0.01% 479
2014
Q1 		$12.3M Buy
+285,000
New +$13.8M 0.01% 479

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates's IONS Position: Q1 2015 in Review

Jennison Associates sold out of Ionis Pharmaceuticals (IONS) in Q1 2015, closing a stake of 1,725,800 shares — an estimated $107M sold.

Jennison Associates first reported a position in IONS in Q2 2013 and held it in 7 quarters. The position peaked at $107M in Q4 2014. 339 funds tracked by Wall St. Rank hold IONS as of Q1 2015.

  • Jennison Associates reported no remaining Ionis Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Jennison Associates sold 1,725,800 Ionis Pharmaceuticals shares in Q1 2015, an estimated $107M.
  • Jennison Associates first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Jennison Associates's Ionis Pharmaceuticals position peaked at $107M in Q4 2014.
  • 339 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2015.

Based on Jennison Associates's 13F filing for Q1 2015, filed 4 May 2015.